20/20 GeneSystems on SeedInvest

Artificial intelligence-powered diagnostics for cancer & COVID-19

Raise to date: $1,999,660

Reporting Date: 08/12/2020

Key Stats

Minimum Raise

$10

Maximum Raise

$14,700,000

Likelihood of Max Unlikely
Start Date

07/08/2020

Stop Date

12/31/2020

Days Remaining

139

Security Type

Preferred Stock

Investment Minimum

$502

Deal Type

No Review


Investment Summary

Status

Active

# of Investors

622

% of Minimum Raised

19,996,600%

% of Maximum Raised

14%

Dollars Per Day to Reach Max

$91,369

DPD* Committed

$57,133

DPD* Category

$0

DPD* All Companies

$1,879

Kingscrowd Momentum

$1,999,660

Total Dollars Raised

Commitments

Weekly Commitments ($)
Aggregate Commitments ($)

SEC Filing Data from Kingscrowd

20/20 GeneSystems, with a pre-money valuation of $38.5 million, is raising funds on SeedInvest through Reg A+ crowdfunding. It is a diagnostics company with a successful track record in cancer detection with its AI-powered multi-cancer blood test, OneTest. The company has recently launched CoronaCheck; its FDA authorized antibody lab test for COVID-19 antibodies. 20/20 GeneSystems was founded by Jonathan Cohen and has raised over $10 million in previous rounds of financing. The current round of funding has round size of $14,700,000, and the proceeds will be used for sales and marketing, research and development, intellectual property development and protection, and cybersecurity and patient privacy protections. 20/20 GeneSystems has already sold over 70,000 COVID-19 antibody tests since its launch in March 2020 and generated over $1.2 million in revenue.

Create your first portfolio
WELCOME TO YOUR OWN INVESTMENTS PORTFOLIO ON KINGSCROWD.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Add 20/20 GeneSystems on SeedInvest
Follow company
Follow 20/20 GeneSystems on SeedInvest
INVEST NOW

Get access to the first and only premium analytics and rating platform that enables informed startup investments.

Become an Informed Investor